In the midst of all the negative stories in the media, ‘TheBetterIndia.com’ is a breath of fresh air, as a platform which carries inspirational stories from across India. No politics, name calling or negativity, it’s online presence enables large-scale impact by inspiring all. The impact is visible in a variety of areas such as influencing […]
Tag: Volume 10-Issue 24
Parsi Times LIFELINE
‘Parsi Times LIFELINE’ is a PT initiative that works towards providing rescue and relief to senior community members who are living in appalling conditions of impoverishment. Parsi Times looks to identify and collect the details of our seniors living in unfortunate conditions. This information will then be shared with our generous community Trusts, which undertake […]
Parsi Embroidery: A Heritage Of Humanity – II
. All Creation is ultimately positive and helpful. It is an optimistic creed which has helped keep a very small, scattered people active across centuries and across several diasporas. This iconography comes to life in traditional Parsi embroidery. Flowers, birds and animals are celebrated as emblems of power, protection and purity. The simurgh and rooster, […]
Do You Have The ‘Guts’ To Good Health?
Water Pickles and Parsi delicacy, ‘Sandhras’, will certainly not be the first examples that jump to mind when you think of healthy eating, but a growing body of research shows that a diet that includes a regular intake of fermented foods, bring in a host of health benefits. Doctors these days recommend people to consume […]
Sad Ending To Iconic Tata-Mistry Partnership
September 22, 2020 marked the beginning to the end of 70-years-plus iconic association between two of our community’s and our nation’s most formidable business groups – Tata Sons and Shapoorji Pallonji Group. After four years of rough litigations, since Cyrus Mistry’s ouster in 2016, Shapoorji Pallonji (SP) Group confirmed its exit from Tata Sons as […]
Tata Group To Launch ‘Feluda’ – India’s First Low Cost Covid-19 Test
– Can Detect COVID In Under An Hour! – On 19th September, 2020, the Drug Controller General of India (DCGI) gave approval for the commercial launch of India’s first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Coronavirus test called ‘Feluda’, developed by the Tata Group and CSIR-IGIB (Institute of Genomics and Integrative Biology). ‘Feluda’ has […]